News

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/23/2019
5:00 PM ET
Press Release

Zymeworks Announces Corporate Update Conference Call

5/23/2019

VANCOUVER, British Columbia--(BUSINESS WIRE)-- Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that ...

 Continue Reading
5/16/2019
6:45 AM ET
Press Release

Zymeworks and GSK Expand 2016 Azymetric™ Bispecific Agreement

5/16/2019

VANCOUVER, British Columbia--(BUSINESS WIRE)-- Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that ...

 Continue Reading
5/14/2019
6:45 AM ET
Press Release

Zymeworks Enters its First ZymeLink™ Antibody-Drug Conjugate Platform Licensing Agreement with Iconic Therapeutics

5/14/2019

Zymeworks eligible to receive milestone payments, royalties, and worldwide co-promotion rightsZymeworks entitled to a share of revenues if Iconic outlicenses the programVANCOUVER, Brit...

 Continue Reading
5/3/2019
6:45 AM ET
Press Release

Zymeworks Announces Election of Directors and Voting Results from Shareholder Meeting

5/3/2019

VANCOUVER, Canada--(BUSINESS WIRE)-- Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, is pleased to announce th...

 Continue Reading
5/2/2019
5:00 PM ET
Press Release

Zymeworks Reports 2019 First Quarter Financial Results

5/2/2019

VANCOUVER, British Columbia--(BUSINESS WIRE)-- Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today reported fin...

 Continue Reading
Displaying 1 to 5 (of 111 releases)